Correlation Between PsyBio Therapeutics and Defence Therapeutics

Can any of the company-specific risk be diversified away by investing in both PsyBio Therapeutics and Defence Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PsyBio Therapeutics and Defence Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PsyBio Therapeutics Corp and Defence Therapeutics, you can compare the effects of market volatilities on PsyBio Therapeutics and Defence Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PsyBio Therapeutics with a short position of Defence Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PsyBio Therapeutics and Defence Therapeutics.

Diversification Opportunities for PsyBio Therapeutics and Defence Therapeutics

0.2

Correlation Coefficient

PsyBio Therapeutics  Defence Therapeutics

Modest diversification

The 3 months correlation between PsyBio and Defence is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding PsyBio Therapeutics Corp and Defence Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Defence Therapeutics and PsyBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PsyBio Therapeutics Corp are associated (or correlated) with Defence Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Defence Therapeutics has no effect on the direction of PsyBio Therapeutics i.e., PsyBio Therapeutics and Defence Therapeutics go up and down completely randomly.

Pair Corralation between PsyBio Therapeutics and Defence Therapeutics

Assuming the 90 days horizon PsyBio Therapeutics Corp is expected to generate 14.14 times more return on investment than Defence Therapeutics. However, PsyBio Therapeutics is 14.14 times more volatile than Defence Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Defence Therapeutics is currently generating about -0.14 per unit of risk. If you would invest  0.40  in PsyBio Therapeutics Corp on September 23, 2024 and sell it today you would lose (0.39) from holding PsyBio Therapeutics Corp or give up 97.5% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

PsyBio Therapeutics Corp  vs.  Defence Therapeutics

PsyBio Therapeutics Corp

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in PsyBio Therapeutics Corp are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental drivers, PsyBio Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Defence Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Defence Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's technical and fundamental indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with PsyBio Therapeutics and Defence Therapeutics

The main advantage of trading using opposite PsyBio Therapeutics and Defence Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PsyBio Therapeutics position performs unexpectedly, Defence Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Defence Therapeutics will offset losses from the drop in Defence Therapeutics' long position.

The idea behind PsyBio Therapeutics Corp and Defence Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.